BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36560741)

  • 1. Severity of COVID-19 among Hospitalized Patients: Omicron Remains a Severe Threat for Immunocompromised Hosts.
    Nevejan L; Ombelet S; Laenen L; Keyaerts E; Demuyser T; Seyler L; Soetens O; Van Nedervelde E; Naesens R; Geysels D; Verstrepen W; Cattoir L; Martens S; Michel C; Mathieu E; Reynders M; Evenepoel A; Hellemans J; Vanhee M; Magerman K; Maes J; Matheeussen V; Boogaerts H; Lagrou K; Cuypers L; André E
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
    Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study.
    COVID-19 Omicron Delta study group
    PLoS One; 2023; 18(4):e0282806. PubMed ID: 37104488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
    Malahe SRK; Hoek RAS; Dalm VASH; Broers AEC; den Hoed CM; Manintveld OC; Baan CC; van Deuzen CM; Papageorgiou G; Bax HI; Van Kampen JJ; Hellemons ME; Kho MML; de Vries RD; Molenkamp R; Reinders MEJ; Rijnders BJA
    Clin Infect Dis; 2023 Feb; 76(3):e172-e178. PubMed ID: 35869843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
    Lauring AS; Tenforde MW; Chappell JD; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Talbot HK; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Halasa N; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Womack KN; Rhoads JP; Lindsell CJ; Hart KW; Zhu Y; Adams K; Schrag SJ; Olson SM; Kobayashi M; Verani JR; Patel MM; Self WH;
    medRxiv; 2022 Feb; ():. PubMed ID: 35169811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022.
    Taylor CA; Whitaker M; Anglin O; Milucky J; Patel K; Pham H; Chai SJ; Alden NB; Yousey-Hindes K; Anderson EJ; Teno K; Reeg L; Como-Sabetti K; Bleecker M; Barney G; Bennett NM; Billing LM; Sutton M; Talbot HK; McCaffrey K; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):466-473. PubMed ID: 35324880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient.
    Alisoltani A; Simons LM; Agnes MFR; Heald-Sargent TA; Muller WJ; Kociolek LK; Hultquist JF; Lorenzo-Redondo R; Ozer EA
    Virol J; 2023 Oct; 20(1):246. PubMed ID: 37891657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.
    Zhang J; Zhao D; Hu J; Huang X; Gu Q; Tao Z
    Front Public Health; 2022; 10():1049006. PubMed ID: 36466505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service.
    Radhakrishnan N; Liu M; Idowu B; Bansari A; Rathi K; Magar S; Mundhra L; Sarmiento J; Ghaffar U; Kattan J; Jones R; George J; Yang Y; Southwick F
    BMC Infect Dis; 2023 Oct; 23(1):747. PubMed ID: 37907849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy.
    Rovida F; Esposito GL; Rissone M; Novelli V; Cutti S; Muzzi A; Rona C; Bertoli E; Daglio M; Piralla A; Paolucci S; Campanini G; Ferrari G; Giardina F; Zavaglio F; Lilleri D; Grugnetti AM; Grugnetti G; Odone A; Marena C; Baldanti F
    Int J Infect Dis; 2022 Sep; 122():420-426. PubMed ID: 35750265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced COVID-19 morbidity and mortality in hemodialysis patients across the various Omicron sublineages-A retrospective analysis.
    Schuller M; Ginthör NE; Paller A; Waller M; Köstenbauer M; Schreiber NGO; Schabhüttl C; Mischinger K; Hafner-Giessauf H; Rosenkranz AR; Eller P; Eller K
    Front Public Health; 2023; 11():1218188. PubMed ID: 37637818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study.
    Paredes MI; Lunn SM; Famulare M; Frisbie LA; Painter I; Burstein R; Roychoudhury P; Xie H; Mohamed Bakhash SA; Perez R; Lukes M; Ellis S; Sathees S; Mathias PC; Greninger A; Starita LM; Frazar CD; Ryke E; Zhong W; Gamboa L; Threlkeld M; Lee J; McDermot E; Truong M; Nickerson DA; Bates DL; Hartman ME; Haugen E; Nguyen TN; Richards JD; Rodriguez JL; Stamatoyannopoulos JA; Thorland E; Melly G; Dykema PE; MacKellar DC; Gray HK; Singh A; Peterson JM; Russell D; Torres LM; Lindquist S; Bedford T; Allen KJ; Oltean HN
    Clin Infect Dis; 2022 Aug; 75(1):e536-e544. PubMed ID: 35412591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
    Stålcrantz J; Kristoffersen AB; Bøås H; Veneti L; Seppälä E; Aasand N; Hungnes O; Kvåle R; Bragstad K; Buanes EA; Whittaker R
    Scand J Public Health; 2022 Aug; 50(6):676-682. PubMed ID: 35799474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.